Search filters

List of works by Kathryn Elisa Burns

A case-control study to assess the ability of the thymine challenge test to predict patients with severe to life threatening fluoropyrimidine-induced gastrointestinal toxicity

scientific article published on 12 December 2019

A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells

scientific article published on 11 December 2019

A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells

scientific article published on 19 July 2019

Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance

2014 doctoral thesis by Kathryn Burns at University of Auckland

CYP2 family: physiological enzymes subset in GtoPdb v.2021.2

scientific article published on 25 June 2021

CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity

scientific article published on 12 February 2014

Circulating microRNA as biomarkers of clozapine-induced cardiotoxicity

scientific article published on 21 November 2019

Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients

scientific article published on 10 June 2021

Cytochrome P450 (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

scientific article published on 16 September 2019

Cytochrome P450 in GtoPdb v.2021.2

scientific article published on 25 June 2021

High CYP2C19 phenotypic variability in gastrointestinal cancer patients

scientific article published on 27 November 2015

Indirect regulation of CYP2C19 gene expression via DNA methylation.

scientific article published on 25 August 2017

Intracellular activation of 4-hydroxycyclophosphamide into a DNA-alkylating agent in human leucocytes

scientific article published on 8 September 2021

Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19

scientific article published on October 10, 2012

Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?

scientific article published on 27 September 2021

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes

scientific article published on 22 July 2019